Filing Details
- Accession Number:
- 0001668397-24-000051
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-03-06 16:42:41
- Reporting Period:
- 2024-03-04
- Accepted Time:
- 2024-03-06 16:42:41
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1668397 | Medpace Holdings Inc. | MEDP | Services-Commercial Physical & Biological Research (8731) | 320434904 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1677399 | J Jesse Geiger | C/O Medpace Holdings, Inc. 5375 Medpace Way Cincinnati OH 45227 | President | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-03-04 | 22,321 | $90.65 | 26,145 | No | 4 | M | Direct | |
Common Stock | Disposition | 2024-03-04 | 22,321 | $403.03 | 3,824 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2024-03-05 | 17,679 | $90.65 | 21,503 | No | 4 | M | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2024-03-04 | 22,321 | $0.00 | 22,321 | $90.65 |
Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2024-03-05 | 17,679 | $0.00 | 17,679 | $90.65 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
17,679 | 2024-08-05 | No | 4 | M | Direct | |
0 | 2024-08-05 | No | 4 | M | Direct |
Footnotes
- The transactions reported on this line of this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.
- The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $401.60 to $404.525. The Reporting Person undertakes to provide full pricing information tothe Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.
- The option vested in full on August 5, 2019.